shortagewatch

Home / Cancer and immune system / Docetaxel

ATC L01CD02 · Antineoplastic Agents

Docetaxel shortage

As of 31 Oct 2026, Docetaxel has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 9 products.

Countries3/5
Products9packs or presentations
Short since3 Oct 202513 months ago
Earliest return31 Oct 2026company estimate
No return date4products
Main reasonManufacturing problem
GermanyNo reported shortageItaly4 packs shortSpain2 packs shortAustriaNo reported shortageBelgium3 packs short

Timeline

ItalySpainBelgium
20262027DOCETAXEL AUROBINDODOCETAXEL AUROBINDODOCETAXEL AUROBINDODOCETAXEL AUROBINDODOCETAXEL ACCORDDOCETAXEL ACCORDDOCETAXEL AUROBINDODOCETAXEL AUROBINDODOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA DOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 16 mlDOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA DOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 8 mlDocetaxel Accord 160 mg/8 ml inf. sol. (concDocetaxel Accord 160 mg/8 ml inf. sol. (conc.) i.v. vial 8 mlDocetaxel Accord 80 mg/4 ml inf. sol. (conc.Docetaxel Accord 80 mg/4 ml inf. sol. (conc.) i.v. vial 4 mlDocetaxel Eugia 20 mg/ml inf. sol. (conc.) iDocetaxel Eugia 20 mg/ml inf. sol. (conc.) i.v. vial 4 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITDOCETAXEL AUROBINDOEugia Pharma (Malta) Limited3 Oct 2025not givenManufacturing problem
Problemi produttivi: distribuzione contingentata
ITDOCETAXEL AUROBINDOEugia Pharma (Malta) Limited27 Apr 2026not givenManufacturing problem
Problemi produttivi: distribuzione contingentata
ITDOCETAXEL ACCORDACCORD HEALTHCARE, S.L.U.6 May 2026not givenRegulatory or licensing
Problemi regolatori
ITDOCETAXEL AUROBINDOEugia Pharma (Malta) Limited12 Aug 2026not givenManufacturing problem
Problemi produttivi
ESDOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 16 mlPfizer S.L.16 Aug 202629 Jun 2027Not stated
ESDOCETAXEL HOSPIRA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 8 mlPfizer S.L.13 Oct 202614 Jun 2027Not stated
BEDocetaxel Accord 160 mg/8 ml inf. sol. (conc.) i.v. vial 8 mlAccord Healthcare22 May 202631 Oct 2026Manufacturing problem
Delay in production
BEDocetaxel Accord 80 mg/4 ml inf. sol. (conc.) i.v. vial 4 mlAccord Healthcare8 Jul 20269 Dec 2026Increased demand
BEDocetaxel Eugia 20 mg/ml inf. sol. (conc.) i.v. vial 4 mlEugia Pharma (Malta)8 Sep 202630 Nov 2026Other
Other reason

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Paclitaxel